PCV74 - COST-EFFECTIVENESS ANALYSIS OF ROSUVASTATIN COMPARED TO ATORVASTATIN IN SPANISH PATIENTS AT MODERATE, HIGH, AND VERY HIGH CARDIOVASCULAR RISK
| Autor: | García-Goñi, M., Fácila, L., Cinza, S., Pinto, X., Cortes, X., Prades, M., Aceituno, S. |
|---|---|
| Zdroj: | In Value in Health October 2018 21 Supplement 3:S104-S105 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect